Stay updated with breaking news from Inborn Errors. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
24.01.2022 - REDWOOD CITY, Calif., Jan. 24, 2022 (GLOBE NEWSWIRE) - Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, today announced that the U.S. Food and Drug Administration (FDA) has granted the ... Seite 1
POXEL SA (Euronext POXEL FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic diseases with metabolic pathophysiology, including non-alcoholic steatohepatitis
/PRNewswire/ -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage company bringing the transformative potential of synthetic biology to medicine, today announced...
PPS was well tolerated with no serious adverse events reported over a 24-week period and there were meaningful improvements in pain, function...
/PRNewswire/ -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage company bringing the transformative potential of synthetic biology to medicine, today announced...